Case-Based MCQs: Renal Physiology (1st Year MBBS)

CASE 1 - Glomerular Filtration Forces

CASE 2 - Renal Clearance and Tubular Handling

CASE 3 - Tubular Reabsorption: Glucose and Tm

CASE 4 - Renin-Angiotensin-Aldosterone System (RAAS)

CASE 5 - ADH and Urine Concentration

CASE 6 - Countercurrent Mechanism

CASE 7 - Autoregulation of RBF and GFR

1. Myogenic reflex - when BP rises, the afferent arteriole stretches, causing it to contract (reducing RBF and preventing the rise in glomerular pressure).
2. Tubuloglomerular feedback (TGF) - increased delivery of NaCl to the macula densa causes afferent arteriole constriction via adenosine/ATP release.

CASE 8 - Acid-Base: Renal Regulation

CASE 9 - Juxtaglomerular Apparatus

CASE 10 - Potassium Balance

• Upregulate ENaC (epithelial Na+ channels) on the luminal membrane → increases Na+ reabsorption
• Upregulate ROMK (K+ channels) on the luminal side → increases K+ secretion into the tubular lumen
• Stimulate basolateral Na/K-ATPase

Quick Reference Summary Table

Why Does Hypokalaemia in Primary Hyperaldosteronism Cause Impaired Glucose Tolerance?

Step 1 - Primary Hyperaldosteronism (1° Hyperaldo)

• Upregulates ENaC → Na⁺ retention → hypertension
• Upregulates ROMK (apical K⁺ channels) → excess K⁺ secretion into urine
• Net result: Hypokalaemia + metabolic alkalosis

Step 2 - The Role of K⁺ in Pancreatic Beta-Cell Physiology

Blood glucose rises
       ↓
Glucose enters beta cell via GLUT2 → metabolized
       ↓
ATP/ADP ratio rises
       ↓
ATP-sensitive K⁺ channels (K_ATP) CLOSE
       ↓
K⁺ can no longer exit → membrane DEPOLARIZES
       ↓
Voltage-gated Ca²⁺ channels open → Ca²⁺ enters
       ↓
Insulin granule exocytosis → INSULIN SECRETED

Step 3 - How Hypokalaemia Blocks This Process

Step 4 - Additional Mechanisms Beyond K⁺ (Direct Aldosterone Effect)

"Aldosterone impairs insulin secretion in isolated islets... After treatment [adrenalectomy or mineralocorticoid receptor antagonist], the C-peptide and insulin response during hyperglycaemic clamp increased significantly (ΔC-peptide +530.5 pmol/L, P=0.004)."

Step 5 - Evidence from Diuretic-Induced Hypokalaemia (Parallel Model)

"The mechanism of impaired glucose tolerance appears to involve reduced insulin secretion... Hyperglycaemia is reduced when K⁺ or a K⁺-sparing diuretic (amiloride) is given along with the thiazide diuretic."

"Hyperglycaemia/glucose intolerance has been linked to diuretic-induced hypokalaemia, with subsequent inhibition of pancreatic β-cell mediated insulin secretion - a likely dose-dependent effect that is potentially reversible upon withdrawal."

Complete Mechanistic Summary Diagram

Primary Hyperaldosteronism (Conn's Adenoma / Bilateral Hyperplasia)
                    ↓
        Excess Aldosterone
       /                    \
↑ Na⁺ reabsorption      ↑ K⁺ secretion in CCD
(via ENaC)                  ↓
  → Hypertension         HYPOKALEMIA (K⁺ < 3.5 mEq/L)
                            ↓
             Beta-cell membrane HYPERPOLARIZES
             (more K⁺ efflux due to ↑ K⁺ gradient)
                            ↓
         K_ATP channels stay open (paradoxically)
         Voltage-gated Ca²⁺ channels do NOT open
                            ↓
         ↓ Ca²⁺ influx → ↓ Insulin exocytosis
                            ↓
         IMPAIRED GLUCOSE TOLERANCE / Diabetes

   PLUS: Direct aldosterone effect on islet MR receptors
         → ↓ Insulin secretion (K⁺-independent pathway)
         → ↑ Insulin clearance

Clinical Correlation - Why This Matters

One-Line Answer for Exams

Impaired Glucose Tolerance (IGT) - What It Means

Simple Definition

The Spectrum of Glucose Homeostasis

Normal Glucose       →      Pre-diabetes       →       Diabetes Mellitus
  Tolerance                (IGT / IFG)
  
  ←————————————————————————————————————————————————————————————→
             (a spectrum, not abrupt categories)

Diagnostic Criteria (OGTT - Oral Glucose Tolerance Test)

• The 2-hour glucose = 140 to 199 mg/dL after a 75 g oral glucose load
• It does NOT meet the ≥ 200 mg/dL cutoff for diabetes

Companion Condition: Impaired Fasting Glucose (IFG)

Why Does It Happen? - The Underlying Physiology

Glucose absorbed → Blood glucose rises
         ↓
Pancreatic beta cells detect rise
         ↓
Rapid FIRST-PHASE insulin release (within 0-10 min)
         ↓
Insulin drives glucose into liver, muscle, fat
         ↓
Blood glucose returns to normal within 2 hours

1. Reduced first-phase insulin secretion - beta cells don't respond quickly enough to the glucose spike
2. Insulin resistance - liver, muscle, and fat cells don't respond well to the insulin that IS secreted
3. Increased hepatic glucose output - the liver keeps releasing glucose even after a meal

Why IGT Matters Clinically

Connecting Back to Primary Hyperaldosteronism

• Hypokalaemia → beta-cell hyperpolarization → blunted first-phase insulin secretion
• This specifically impairs the 0-30 minute insulin response to glucose
• The 2-hour glucose therefore stays elevated in the 140-199 mg/dL range = IGT
• Once the K⁺ is corrected (spironolactone or adrenalectomy), beta-cell function can recover and glucose tolerance normalises - which is why IGT in primary hyperaldosteronism is potentially reversible, unlike primary T2DM

Mechanism of Action of Insulin via the Insulin Receptor

The Insulin Receptor - Structure First

• Receptor density varies enormously: 40 receptors/cell on erythrocytes → 300,000 receptors/cell on hepatocytes and adipocytes
• Insulin binds with picomolar affinity (extremely high sensitivity)

The Signaling Cascade - Step by Step

STEP 1 - Insulin Binding → Conformational Change

• Insulin binds to the α subunits on the extracellular surface
• The α subunits normally inhibit the β subunit kinase activity
• Binding releases this inhibition and causes a conformational change that brings the two cytoplasmic β subunit tails into close proximity

STEP 2 - Autophosphorylation (Tyrosine Kinase Activation)

• The two β subunits transphosphorylate each other - each phosphorylates tyrosine (Y) residues on the other's cytoplasmic tail
• This is called autophosphorylation
• Key tyrosines phosphorylated span from the juxtamembrane region to the intracellular tail
• Result: the receptor's intrinsic tyrosine kinase is now fully active

Resting state:      α ——[inhibits]——  β (kinase OFF)
After insulin:      α-insulin         β-P (kinase ON) ←→ β-P
                                      ↑ mutual transphosphorylation

STEP 3 - IRS Protein Phosphorylation (First Docking Step)

• The activated receptor now phosphorylates IRS proteins (Insulin Receptor Substrates 1-4) on multiple tyrosine residues
• IRS proteins are docking/adaptor proteins - they have no enzymatic activity themselves but carry SH2-domain binding motifs
• Phosphorylated IRS proteins then recruit and activate downstream effectors

STEP 4 - TWO Major Downstream Pathways Branch Off

Pathway A: PI3K → Akt → GLUT4 (Metabolic Pathway)

IRS (phosphorylated)
       ↓
Activates PI3K (Phosphatidylinositol-3-Kinase)
       ↓
PI3K generates PIP₃ (Phosphatidylinositol 3,4,5-trisphosphate) at membrane
       ↓
PIP₃ recruits and activates PDK-1 (Phosphoinositide-dependent kinase-1)
       ↓
PDK-1 phosphorylates and activates Akt2 (PKB - Protein Kinase B)
       ↓
Akt2 substrates:
  ├── GLUT4 vesicle translocation → glucose uptake ↑
  ├── Glycogen synthase kinase 3 (GSK-3) inhibited → Glycogen synthase ACTIVE → Glycogen synthesis ↑
  ├── mTOR activation → Protein synthesis ↑
  └── Inhibits gluconeogenesis in liver

Pathway B: Shc → Ras → MAPK (Mitogenic Pathway)

Receptor also phosphorylates Shc (Src-homology protein)
       ↓
Shc recruits Grb2 (Growth factor receptor-binding protein 2)
       ↓
Grb2 activates SOS (guanine nucleotide exchange factor)
       ↓
SOS activates Ras (GTP-binding protein)
       ↓
Ras → Raf → MEK → MAPK (MAP Kinase / ERK)
       ↓
Nuclear effects: gene transcription, cell growth, differentiation, survival

Pathway C: Caveolar Pathway (Alternative GLUT4 route)

• In the caveola (lipid raft microdomains), the insulin receptor phosphorylates Cav (caveolin), APS, and Cbl
• Cbl recruits CAP → CrkII → C3G → activates TC10 (small GTPase)
• TC10 coordinates actin cytoskeleton remodeling needed for GLUT4 vesicle docking at the plasma membrane
• Works in parallel with the PI3K pathway to ensure GLUT4 translocation

STEP 5 - GLUT4 Translocation (The Key Glucose Uptake Step)

Resting state:
   ~95% of GLUT4 is stored inside the cell in
   "GLUT4-enriched vesicles" (intracellular compartment)
   → Very little glucose enters the cell

After insulin signaling (Akt2 + TC10 activation):
   GLUT4 vesicles move to the plasma membrane
   GLUT4 inserts into the membrane (exocytosis)
   Insulin also REDUCES GLUT4 endocytosis
   → More GLUT4 stays on the surface longer
   → Glucose enters by FACILITATED DIFFUSION down its concentration gradient

STEP 6 - Intracellular Glucose Metabolism

Glucose
   ↓ (Hexokinase II - also upregulated by insulin)
Glucose-6-Phosphate (G6P)
   ├── → Glycogen (via glycogen synthase - activated by insulin)
   ├── → Glycolysis (ATP production)
   └── → Pentose phosphate pathway (NADPH, nucleotide synthesis)

Complete Summary Table of Insulin's Cellular Effects

Signal Termination

• Protein tyrosine phosphatases - especially PTP1B which dephosphorylates the receptor and IRS proteins
• Receptor internalization (endocytosis) after insulin binding
• PI-3 phosphatases (PTEN, SHIP2) that break down PIP₃

Connecting to Insulin Resistance (T2DM)

• Serine phosphorylation (not tyrosine) of IRS-1 by inflammatory signals (TNF-α, free fatty acids, JNK kinase) blocks downstream signaling
• PI3K/Akt pathway is blunted → reduced GLUT4 translocation → hyperglycaemia
• MAPK pathway is often preserved → continued cell growth effects (one reason for cardiovascular complications)

One-Line Exam Summary

Insulin binds α subunits of its tetrameric RTK receptor → releases inhibition of β subunit tyrosine kinase → autophosphorylation → IRS proteins phosphorylated → (1) PI3K/Akt/GLUT4 pathway mediates glucose uptake and glycogen synthesis; (2) Shc/Ras/MAPK pathway mediates cell growth and gene transcription.

Insulin Receptor - Simple Explanation

Think of it Like a DOOR and a KEY 🔑

Insulin = the Key Insulin Receptor = the Lock + Door mechanism GLUT4 = the door for glucose to enter the cell

The Receptor Structure (Simple)

OUTSIDE the cell:    [α]———[α]      ← these grab insulin
                      |       |
INSIDE the cell:     [β]   [β]      ← these do the work

• α parts → outside → hold insulin
• β parts → inside → have the "engine" (tyrosine kinase = a phosphorylating enzyme)

What Happens Step by Step

🔴 BEFORE Insulin (fasting state)

• The α parts are sitting on top of β parts and blocking them
• The engine is OFF
• GLUT4 channels are hiding inside the cell
• Glucose cannot enter the cell

🟢 AFTER Insulin Binds (fed state)

Insulin binds to the α subunits
         ↓
α subunits change shape
         ↓
They STOP blocking the β subunits

β subunit 1 adds a phosphate (P) to β subunit 2
β subunit 2 adds a phosphate (P) to β subunit 1
         ↓
Both β subunits are now ACTIVE
(This is called autophosphorylation)

Active β subunits grab IRS proteins
(IRS = Insulin Receptor Substrate = a "messenger")
         ↓
IRS proteins get phosphorylated (switched ON)
         ↓
IRS now go and deliver the message inside the cell

The Two Pathways (Super Simple)

Path 1 - The GLUCOSE PATH (most important)

IRS → activates PI3K
              ↓
         PI3K makes PIP₃
              ↓
         PIP₃ activates Akt (also called PKB)
              ↓
         Akt tells GLUT4 vesicles:
         "GO TO THE SURFACE!"
              ↓
    GLUT4 channels pop up on the cell membrane
              ↓
    Glucose rushes INTO the cell
    Blood sugar FALLS ✅

Key point: GLUT4 is normally hiding inside the cell. Insulin is the only signal that brings it to the surface in muscle and fat cells.

Path 2 - The GROWTH PATH

IRS → activates MAPK pathway
              ↓
    Cell growth, protein synthesis,
    cell survival, gene activation

What Happens to Glucose Once Inside?

Glucose enters via GLUT4
         ↓
Hexokinase converts it to Glucose-6-Phosphate
         ↓
    ┌────────────────────────┐
    ↓                        ↓
Stored as GLYCOGEN      Burned for ENERGY (ATP)
(in liver & muscle)     (glycolysis)

• Stops the liver from making new glucose (gluconeogenesis OFF)
• Stops fat breakdown (lipolysis OFF)
• Promotes fat storage (lipogenesis ON)
• Drives K⁺ into cells (that's why insulin is used to treat high potassium in emergencies)

The FULL Picture in One Diagram

              INSULIN
                 ↓
         [α]———[α]   ← insulin binds here
          |       |
         [β]-P-[β]   ← autophosphorylation (engine ON)
                 ↓
            IRS proteins
           ↙           ↘
      PI3K pathway    MAPK pathway
           ↓               ↓
    Akt activation    Ras → ERK
           ↓               ↓
   GLUT4 → surface    Cell growth
           ↓
   GLUCOSE enters cell
           ↓
   Glycogen + Energy

Memory Trick

• I - Insulin binds α subunit
• B - Beta subunit autophosphorylation
• M - Messenger IRS activated
• G - PI3K → Akt → GLUT4 translocation
• A - Akt also activates glycogen synthesis
• G - Glucose enters, blood sugar falls

Why This Matters in Disease

What is Akt? - Simple Explanation

The Name First

What Kind of Protein is Akt?

• When Akt is inactive → sitting in the cytoplasm, doing nothing
• When Akt is active → it goes around phosphorylating (switching ON/OFF) many target proteins

Where Does Akt Sit in the Insulin Pathway?

Insulin
   ↓
Receptor tyrosine kinase activated
   ↓
IRS proteins activated
   ↓
PI3K activated
   ↓
PI3K makes PIP₃ (a lipid signal at the membrane)
   ↓
PIP₃ recruits Akt to the membrane
   ↓
PDK-1 phosphorylates Akt → Akt is NOW ACTIVE ✅
   ↓
Akt goes and does its jobs...

What Does Akt Actually Do? (Its Jobs)

            ACTIVE Akt
               ↓
    ┌──────────┼──────────┬────────────┐
    ↓          ↓          ↓            ↓
GLUT4       GSK-3      FOXO1        mTOR
moves to   turned      turned      activated
surface    OFF         OFF
    ↓          ↓          ↓            ↓
Glucose    Glycogen   Stops       Protein
enters     synthesis  making new  synthesis
cell       turns ON   glucose     increases

Job by job:

• Akt (specifically the Akt2 isoform) signals GLUT4 vesicles to move to the cell surface
• This is the main way insulin lowers blood glucose in muscle and fat

• Akt phosphorylates and switches OFF GSK-3 (glycogen synthase kinase-3)
• GSK-3 normally blocks glycogen synthase
• When GSK-3 is OFF → glycogen synthase turns ON → glycogen is made
• Think: Akt turns OFF the "glycogen blocker"

• Akt phosphorylates and inactivates FOXO1 (a transcription factor)
• FOXO1 normally turns ON genes for gluconeogenesis (making new glucose)
• When FOXO1 is OFF → liver stops making glucose → blood sugar falls further

• Akt activates mTOR (mammalian target of rapamycin)
• mTOR promotes protein synthesis → muscle growth, cell building

• Akt phosphorylates and inactivates Bad (a pro-apoptosis protein)
• Cell does NOT die → survival promoted

Simple Analogy

Imagine Akt is like a factory supervisor who just got orders from head office (insulin). The supervisor runs around telling each department what to do:

• "Glucose department - open the gates (GLUT4)!"
• "Storage department - start making glycogen!"
• "Fuel department - stop making new glucose!"
• "Construction department - build more proteins!"

The 3 Isoforms of Akt (Simple)

Why Akt is Important in Disease

One-Line Summary

Akt (PKB) is a serine/threonine kinase activated by PI3K/PIP₃ during insulin signaling - it is the central "relay switch" that drives GLUT4 to the cell surface, activates glycogen synthesis, suppresses liver glucose production, and promotes protein synthesis.